SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-23-097753
Filing Date
2023-12-21
Accepted
2023-12-21 17:21:53
Documents
18
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2023a1_inmedphar.htm   iXBRL 10-K/A 54406
2 CONSENT OF MARCUM LLP f10k2023a1ex23-1_inmedphar.htm EX-23.1 2981
3 CERTIFICATION f10k2023a1ex31-1_inmedphar.htm EX-31.1 9246
4 CERTIFICATION f10k2023a1ex31-2_inmedphar.htm EX-31.2 9341
5 CERTIFICATION f10k2023a1ex32-1_inmedphar.htm EX-32.1 3402
6 CERTIFICATION f10k2023a1ex32-2_inmedphar.htm EX-32.2 3365
  Complete submission text file 0001213900-23-097753.txt   323013

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE inm-20230630.xsd EX-101.SCH 3256
8 XBRL DEFINITION FILE inm-20230630_def.xml EX-101.DEF 17747
9 XBRL LABEL FILE inm-20230630_lab.xml EX-101.LAB 36794
10 XBRL PRESENTATION FILE inm-20230630_pre.xml EX-101.PRE 18886
12 EXTRACTED XBRL INSTANCE DOCUMENT f10k2023a1_inmedphar_htm.xml XML 5886
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-39685 | Film No.: 231506218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)